Medicines and vaccines are transforming our lives like never before. We represent the companies that make them possible. 📨 PressOffice@abpi.org.uk

United Kingdom
The ABPI’s 2026 flagship Competitiveness Report finds that the UK has begun to reverse years of decline. Sustained delivery of government commitments will now determine whether the recovery holds: abpi.org.uk/media/news/2026/…
170
We were very pleased to support the Editor award! Well done to @munkeatlooi and all those who were shortlisted. @mjauk @bmj_latest #MJAAwards 🏆
The penultimate award is for Editor. And the winner is Mun Keat Looi @bmj_latest Congratulations @Munkeatlooi @ABPI_UK #MJAAwards
1
1
3
402
At today's Regulatory Science Symposium, our final panel session discussed how the UK can best use its regulatory framework to benefit patients. Everybody wants to see the UK lead the world on access to innovative medicines.
171
At our regulatory science symposium, our colleague Jas Dhaliwal-Rahi talked about where the UK can improve its regulatory offer and lead internationally in regulatory innovation. @MHRAgovuk
1
166
At our Regulatory Science Symposium, the @MHRAgovuk talked about improvements it has made, including to approval times for new medicines, and a partnership with the US FDA that will support scientific exchange.
146
Today’s Regulatory Science Symposium brought together key innovation bodies. The Regulatory Innovation Office removes barriers slowing new technologies @ARIA_research prioritises the scientific areas with greatest breakthrough potential @LifeArc transforms lives of people with rare diseases Together: scientific breakthroughs.
113
The ABPI's third Regulatory Science Symposium is under way today, exploring how the UK can lead on regulatory innovation and scientific breakthroughs. We will discuss where the UK's regulatory offer can be genuinely distinctive. @MHRAgovuk
1
148
A year ago, the UK was losing ground on pharmaceutical investment. Today the picture is more hopeful: £2bn of new investment committed since September 2025. But the recovery is not yet secure. Our 2026 competitiveness report benchmarks the UK against 12 markets: abpi.org.uk/publications/uk-…
1
127
Great to have be at yesterday's #NHSScotlandEvent, with @UofGRegiusAnna, @GardnerJann & @alisonstrath to discuss Scotland's future in health research & innovation. Key message: collaboration between the NHS, industry, academia and government is key. 🤝 #LifeSciences #TripleHelix
3
5
427
Pleased to be at the NHS Scotland Event 2026 on 21 Sept! Our Chief Exec @TorbettR joins a panel on securing Scotland's future through health research & innovation, alongside @UofGRegiusAnna, @alisonstrath, @GardnerJann & the ABPI's Michelle Conway. 📍 Uni of Strathclyde, 12.40-13.20 In-person is sold out - register to join virtually: nhsscotlandevents.com/nhs-sc… #NHSScotlandEvent2026 #LifeSciences
1
2
266
Can the UK and Europe regain their place as top destinations for clinical trials? ABPI Chief Executive Richard Torbett joins the @FT Global Pharma & Biotech Summit to discuss this important topic. ABPI members save 20% off passes; email membership@abpi.org.uk for the code. 🧵(1/3)
1
222
📅 @FT Global Pharma & Biotech Summit | 10-11 Nov 2026 | Convene 22 Bishopsgate, London The summit brings together the leaders, investors and policymakers shaping life sciences' next phase. ABPI members save 20% off passes; email membership@abpi.org.uk for the code. (2/3)
1
100
Also speaking at the @FT Global Pharma & Biotech Summit: ➡️ Lawrence Tallon, CEO, MHRA ➡️ Shreeram Aradhye, President Development & CMO, Novartis ➡️ Kim Branson, Chief AI Officer, GSK ➡️ Nathalie Moll, DG, EFPIA ➡️ Peter Wickersham, VP & GM UK/Ireland, Gilead Plus many more. ABPI members save 20% off passes; email membership@abpi.org.uk for the code. (3/3)
124
It's Scottish party conference season and our colleagues are attending: 📍 Scottish Liberal Democrats Conference - 10 Oct 📍 SNP Conference - fringe event on 15 Oct, and the business breakfast with the First Minister on 16 Oct 📍 Scottish Greens Conference - 24–25 Oct We'll be championing life sciences' contribution to Scotland's economy and patient outcomes. Read our manifesto for health and growth in Scotland. abpi.org.uk/publications/abp…
255
Our new Competitiveness Report 2026 confirms the shift: £2 billion of new pharma investment has been committed to the UK since September 2025. Policy certainty and UK strengths in science, IP, and talent are driving this recovery. Now we must deliver on every commitment to keep the momentum going. 🇬🇧💊 thetimes.com/business/compan…
202
It's party conference season, and we're busy! At Labour and Conservative Conferences, we're hosting two must-see panel sessions with @TotalPolitics. Bring your questions and join the conversation. 🧵 📍 Labour Conference, Liverpool Mon 28 Sept, 10:30–11:30, Room 4A (inside secure area) "How Britain as a life sciences superpower can deliver for patients" With ABPI President Russell Abberley. (1/2) #PartyConference2026 #LifeSciences
1
230
📍 Conservative Conference, Birmingham Mon 5 Oct, 10:30–11:30, H&C Room (inside secure area) "How can we regain the UK's competitive edge in life sciences?" With ABPI Vice President Laura McMullin. We'd love to see you there. (2/2)
77
.@NICEComms has switched how it measures treatment benefits. The shift from EQ-5D-3L to 5L could restrict access to medicines that improve quality of life without extending survival. We're calling for close monitoring. Read our latest on what's changing and why it matters 👇 #MedicinesAccess #niceeeeee abpi.org.uk/media/blogs/2026…
1
3
281